Windlas Biotech Ltd share price logo

Windlas Biotech Ltd Share Price

(WINDLAS)

₹1024.80.88%

as on 11:24AM, 02 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Windlas Biotech Performance

  • Day's Low

    Day's High

    ₹996.35
    Day's Price Range
    ₹1,037
  • 52 Week's Low

    52 Week's High

    ₹495.65
    52-Week Price Range
    ₹1,198.25
1 Month Return+ 22.91 %
3 Month Return-0.62 %
1 Year Return+ 84.26 %
Previous Close₹1,015.85
Open₹1,022.95
Volume24.35K
Upper Circuit₹1,219.00
Lower Circuit₹812.70
Market Cap₹2,123.16Cr

Windlas Biotech Fundamentals

P/E Ratio

34.34

PEG Ratio

7.79

Market Cap

₹2,123.16 Cr

P/B Ratio

2.37

EPS

27.98

Dividend Yield

1.07

Sector

Pharmaceuticals

ROE

13.63

Key events for Windlas Biotech Ltd

  • Windlas Biotech Schedules Investor Engagement Meeting - 12 Mar, 2025

    Windlas Biotech Ltd. has announced a virtual investor meeting on March 17, 2025, aimed at enhancing stakeholder engagement and ensuring transparency in operations.
  • Windlas Biotech Hits Upper Circuit After Bulk Deal - 20 Feb, 2025

    Windlas Biotech shares surged 20% to Rs 811.20 following a bulk deal. The company reported strong financial growth, with a 22% YoY EBITDA increase.

Insights on Windlas Biotech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 9 quarters, 121.87 Cr → 199.13 Cr (in ₹), with an average increase of 5.9% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, WINDLAS stock has moved up by 5.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 62.51% of holdings in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.00% to 1.55% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 15.66 Cr → 15.58 Cr (in ₹), with an average decrease of 0.5% per quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 7.57% to 7.11% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 25.91% to 25.68% in Dec 2024 quarter

Windlas Biotech Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹162.21Cr (-)₹171.29Cr (↑5.60%)₹175.15Cr (↑2.25%)₹187.00Cr (↑6.77%)₹195.02Cr (↑4.29%)
Net Income₹15.10Cr (-)₹16.99Cr (↑12.52%)₹13.48Cr (↓20.66%)₹15.66Cr (↑16.17%)₹15.58Cr (↓0.51%)
Net Profit Margin9.31% (-)9.92% (↑6.55%)7.70% (↓22.38%)8.37% (↑8.70%)7.99% (↓4.54%)
Value in ₹ crore
Details2021202220232024
Total Assets₹296.00Cr (-)₹492.07Cr (↑66.24%)₹530.64Cr (↑7.84%)₹628.91Cr (↑18.52%)
Total Liabilities₹97.01Cr (-)₹96.94Cr (↓0.07%)₹127.98Cr (↑32.02%)₹178.62Cr (↑39.57%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹20.87Cr (-)₹11.45Cr (↓45.14%)₹9.00Cr (↓21.40%)₹60.98Cr (↑577.56%)₹108.91Cr (↑78.60%)

Windlas Biotech Index Inclusions

BSE Healthcare

₹40,954.13

0.29 (119.07%)

BSE Small-Cap

₹46,816.59

0.31 (144.66%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Windlas Biotech Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
62.51%
0.00
Foreign Institutions
1.55%
-22.24
Mutual Funds
7.11%
-6.13
Retail Investors
25.68%
-0.89
Others
3.15%
56.55

Windlas Biotech Key Indicators

Details20202021202220232024
Return On Assets %4.715.357.748.039.25
Details202220232024
Book Value Per Share (₹)181.14192.24216.34
Details202220232024
Earning Per Share (₹)17.4820.3727.98
Details20202021202220232024
Return On Equity %10.949.3912.9810.6913.63

Windlas Biotech Valuation

Windlas Biotech in the last 5 years

  • Overview

  • Trends

Lowest (10.46x)

March 28, 2023

Today (34.34x)

April 1, 2025

Industry (53.05x)

April 1, 2025

Highest (38.93x)

December 6, 2024

LowHigh

Windlas Biotech Earnings and Dividends

  • Windlas Biotech Ltd Earnings Results

    Windlas Biotech Ltd’s net profit jumped 3.18% since last year same period to ₹15.58Cr in the Q3 2024-2025. On a quarterly growth basis, Windlas Biotech Ltd has generated -0.51% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Windlas Biotech Ltd Dividends May,2024

    In the quarter ending March 2024, Windlas Biotech Ltd has declared dividend of ₹5.50 - translating a dividend yield of 0.54%.

    Read More about Dividends

Windlas Biotech Technicals Summary

Bearish

Neutral

Bullish

Bullish

Windlas Biotech Ltd is currently in a Bullish trading position according to technical analysis indicators.

Windlas Biotech Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹2,123.16 Cr29.9%0.51₹58 Cr₹630 Cr
HOLD₹14,417.45 Cr11.17%0.54₹1,388 Cr₹3,998 Cr
NA₹132.49 Cr72.6%0.57NANA
NA₹7.38 Cr28.04%29.50NANA
NA₹2,125.24 Cr17.08%0.79NANA

About Windlas Biotech

Windlas Biotech Ltd was founded in 2001 and is a leading provider of pharmaceutical services, development, manufacturing services, and products. The company has a manufacturing plant in Dehradun, Uttarakhand, India and a sales force and distribution network across 14 states. Additionally, it provides CDMO services and products, domestic trade generics and OTC brands, and exports. The company specializes in complex generics products and fixed dose combinations linked to lifestyle-related diseases, as well as drug-device combos. It has adopted high quality systems across its factories and processes that span from product innovation to customer intake. In addition to this, multiple vendors are approved and assessed for sourcing the raw materials.

Revenue: ₹195.02Cr as on December 2024 (Q4 24)
Net Profit: ₹15.58Cr as on December 2024 (Q4 24)
Listing date: 16 Aug, 2021
Chairperson Name: Vivek Dhariwal
OrganisationWindlas Biotech
HeadquartersGurgaon
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Windlas Biotech Ltd

What is Windlas Biotech Ltd price today?

Windlas Biotech Ltd share price today stands at ₹1024.8, Open: ₹1022.95, Previous Close: ₹1015.85, High: ₹1037, Low: ₹996.35, 52 Week High: ₹1198.25, 52 Week Low: ₹495.65.

How to Buy Windlas Biotech Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Windlas Biotech Ltd shares

What are today's traded volumes of Windlas Biotech Ltd?

Today's traded volume of Windlas Biotech Ltd(WINDLAS) is 24.35K.

What is today's market capitalisation of Windlas Biotech Ltd?

Today's market capitalisation of Windlas Biotech Ltd(WINDLAS) is ₹2123.16Cr.

What is the 52 Week High and Low Range of Windlas Biotech Ltd?

Windlas Biotech Ltd (WINDLAS)
Price
52 Week High
₹1198.25
52 Week Low
₹495.65

How much percentage Windlas Biotech Ltd is down from its 52 Week High?

Windlas Biotech Ltd (WINDLAS) share price is ₹1024.8. It is down -14.48% from its 52 Week High price of ₹1198.25

How much percentage Windlas Biotech Ltd is up from its 52 Week low?

Windlas Biotech Ltd (WINDLAS) share price is ₹1024.8. It is up 106.76% from its 52 Week Low price of ₹495.65